DRD2 and Parkinson disease: Notably, stimulation of A2A AR/D2 R heteromers counteracts the D2 R-mediated inhibition of N-methyl-D-aspartate (NMDA) receptor activity [28], a mechanism implicated in the motor dysfunction characteristic of Parkinson’s disease (PD) [29].